A plan has been announced to cut the cost of weight loss drugs and expand access to them. The plan appears to involve deals with drug manufacturers, including Eli Lilly and Novo Nordisk, and may include a new payment model and lower prices for some Americans, potentially including those with Medicare coverage. The extent to which the plan will lower costs and expand access, including for those with employer-based health plans, is not entirely clear.